FDA Drug recall D-1657-2019
EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701
- FDA Drug
- Class II
- terminated
- Published 2019-08-14
On 2019-08-14 the FDA classified a Class II recall of EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701 by Rxq Compounding, citing lack of Assurance of Sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1657-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-06-19 |
| Published | 2019-08-14 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Rxq Compounding |
| Distribution | US |
Product
EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0947-01
Reason
Lack of Assurance of Sterility
Identifiers
| code_info | All lots within expiry |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1657-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.